Research Triangle Park, NC, United States of America

Brian Alvin Johns

This inventor holds 55 USPTO granted patents and 35 published patent applications, plus 3 CIPO patents and 24 EPO patents, primarily in HIV Therapeutics (CPC class C07D). Top assignees: Shionogi Company Limited, Viiv Healthcare Company, Smithkline Beecham Corporation. Active years: 2005-2022.

USPTO Granted Patents = 55 (Patent Applications = 35)

% Patents Active = 52.7

CIPO Patents = 3 (Patent Applications = 12)

EPO Patents = 24 (Patent Applications = 42)

Average Co-Inventor Count = 2.9

ph-index = 10

Forward Citations = 316(Granted Patents)

Forward Citations (Not Self Cited) = 289(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Durham, NC (US) (2005 - 2015)
Research Triangle Park, NC (US) (2012 - 2022)

Company Filing History:

23 out of 1,001

Shionogi Company Limited

patents

21 out of 42

Viiv Healthcare Company

patents

17 out of 2,198

Smithkline Beecham Corporation

Viiv Healthcare UK Limited

patents

6. 1 out of 95

Glaxosmithkline Intellectual Property (No.2) Limited

patents

7. 1 out of 240

Glaxosmithkline Intellectual Property Development Limited

patents

8. 1 out of 965

The Board of Regents of the University of Nebraska

patents

where one patent can have more than one assignee

Years Active: 2005-2022

Loading Chart...

Areas of Expertise:

HIV Integrase Inhibitors

Antiviral Agents

Pharmaceutical Compositions

Betulin Derivatives

Isoindoline Compounds

Pyrrolopyridinone

Prodrugs

Chemical Compounds

Naphthyridine

Indoleamine Modulators

Long Acting Compositions

Carbamoylpyridone

55 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11267823 - Substituted 1,2,3,3a,4,5,7,9,13,13a-decahydropyrido[1',2′:4,5]pyrazino[1,2-a]pyrrolo[1,2-c]pyrimidines having HIV integrase inhibitory activity (2022-03-08),

2. 11117904 - Compositions and methods for the delivery of therapeutics (2021-09-14),

3. 10927129 - N-[(2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3] oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide having HIV integrase inhibitory activity (2021-02-23),

4. 10538495 - Modulators of indoleamine 2,3-dioxygenase (2020-01-21),

5. 10239840 - Benzoazepine derivatives (2019-03-26),

6. 10118894 - Isoindolinone derivatives useful as antiviral agents (2018-11-06),

7. 10112899 - Isoindoline derivatives for use in the treatment of a viral infection (2018-10-30),

8. 10092523 - Long acting pharmaceutical compositions (2018-10-09),

9. 10064873 - Compounds and compositions for treating HIV with derivatives of Betulin (2018-09-04),

10. 9802898 - Phenyl and tertbutylacetic acid substituted pyridinones having anti-HIV effects (2017-10-31),

11. 9795619 - Pharmaceutical compositions (2017-10-24),

12. 9707246 - Substituted (3S,11AR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11A-hexahydro[1,3]oxazolo[3,2-A]pyrido[1,2-D]pyrazine-8-carboxamides as HIV agents (2017-07-18),

13. 9365587 - Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates (2016-06-14),

14. 9340513 - Propenoate derivatives of betulin (2016-05-17),

15. 9273065 - Substituted pyrido[1',2':4,5]pyrazino[1,2-a]pyrimidines as HIV integrase inhibitors (2016-03-01),

Title: The Innovative Journey of Brian Alvin Johns

Introduction:

Brian Alvin Johns is a visionary inventor based in Research Triangle Park, NC. With a passion for pushing the boundaries of technology, he has made significant contributions to the field of innovation.

Latest Patents:

Brian Alvin Johns holds several patents in various technological domains, showcasing his versatility and creativity in inventing cutting-edge solutions for complex problems.

Career Highlights:

Throughout his illustrious career, Brian Alvin Johns has demonstrated a keen ability to transform ideas into tangible inventions. His innovative spirit has led to the development of groundbreaking technologies that have revolutionized industries.

Collaborations:

Brian Alvin Johns has collaborated with leading research institutions, universities, and companies to further his inventions. His collaborative efforts have resulted in the creation of impactful solutions that have garnered recognition worldwide.

Conclusion:

In conclusion, Brian Alvin Johns stands as a beacon of innovation in Research Triangle Park, NC, inspiring others to think outside the box and pursue their inventive ideas. His remarkable contributions to the world of technology continue to shape the future of innovation.